CampbellNRKhanNAHillMD. The Canadian Hypertension Education Program recommendations: the scientific summary — an annual update. Can J Cardiol2009;25(5): 271–7
2.
PadwalRSHemmelgarnBRKhanNA. The Canadian Hypertension Education Program recommendations for the management of hypertension: part 1 — blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol2009;25(5):279–86
3.
KhanNAHemmelgarnBRHermanRJ. The Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 — therapy. Can J Cardiol2009;25(5):287–98
4.
MachadoMBajcarJGuzzoGCEinarsonTR. Sensitivity of patient outcomes to pharmacist interventions. Part II: systematic review and meta-analysis in hypertension management. Ann Pharmacother2007;41:1770–81
5.
ChanAHWCampbellNRLewanczukRZ.for the CHEP Implementation Task Force. 2008 Canadian Hypertension Education Program guidelines for the management of hypertension by pharmacists. Can Pharm J2008;141(6):327–31
6.
McLeanDLMcAlisterFAJohnsonJA.,for the SCRIP-HTN Investigators. A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus. Arch Intern Med2008;168(21):2355–61.
7.
JonesCSimpsonSHMitchellD. Enhancing hypertension awareness and management in the elderly: lessons learned from the Airdrie Community Hypertension Awareness and Management Program (A-CHAMP). Can J Cardiol2008;24(7):561–7
8.
ONTARGET investigators. Telmisartan, ramipril or both in patients at high risk for vascular events. N Engl J Med2008;358:1547–59
9.
MannJFSchmiederREMcQueenM. Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet2008;372:547–53
10.
BulpittCFletcherABeckettN. Hypertension in the very elderly trial (HYVET): protocol for the main trial. Drugs Aging2001;18(3):151–64
11.
BeckettNSPetersRFletcherAE. Treatment of hypertension in patients aged 80 years and older. N Engl J Med2008;358:1887–98
12.
GueyffierFBulpittCBoisselJP. Antihypertensive drugs in very old people: a subgroup meta-analysis of randomized controlled trials. Lancet1999;353(9155):793–6
13.
O'RourkeMFNamasivayamMAdjiA. Treatment of hypertension in patients 80 years of age or older. Minerva Med2009;100:25–38
14.
NeutelCICampbellNR. Changes in lifestyle after hypertension diagnosis in Canada. Can J Cardiol2008;24:199–204
15.
ElmerPJObarzanekEVollmerWM. Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control: 18-month results of a randomized trial. Ann Intern Med2006;144:485–95
16.
HeFJMacGregorGA. Effect of longer-term modest salt reduction on blood pressure. Cochrane Database Syst Rev2004;(3):CD004937
17.
JoffresMRCampbellNRCMannsBTuK. Estimate of the benefits of a population-based reduction in dietary sodium additives on hypertension and its related health care costs in Canada. Can J Cardiol2007;23:437–43
18.
PenzEDJoffresMRCampbellNR. Reducing dietary sodium and decreases in cardiovascular disease in Canada. Can J Cardiol2008;24:497–501
19.
AppelLJMooreTJObarzanekE. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med1997;336:1117–24
20.
WheltonSPChinAXinXHeJ. Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials. Ann Intern Med2002;136:493–503
21.
The Trials of Hypertension Prevention Collaborative Research Group. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, Phase II. Arch Intern Med1997;157:657–67
22.
CromwellJBartoschWJFioreMC. Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. JAMA1997;278:1759–66
23.
FlemingMFBarryKLManwellLB. Brief physician advice for problem alcohol drinkers. A randomized controlled trial in community-based primary care practices. JAMA1997;277:1039–45
24.
Family Heart Study Group. Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British Family Heart Study. BMJ1994;308:313–20
25.
CampbellNRSoLAmankwahE. Characteristics of hypertensive Canadians not receiving drug therapy. Can J Cardiol2008;24:485–90
26.
SowersJREpsteinMFrohlichED. Diabetes, hypertension, and cardiovascular disease: an update. Hypertension2001;37:1053–9
27.
LeenenFHDumaisJMcInnisNH. Results of the Ontario survey on the prevalence and control of hypertension. CMAJ2008;178:1441–9
28.
McMurrayJJVÖstergrenJSwedbergK. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial. Lancet2003;362:767–71
29.
GanzDABaoYShekellePGRubensteinLZ. Will my patient fall?JAMA2007;297:77–86
30.
JohnsonAGNguyenTVDayRO. Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis. Ann Intern Med1994;121:289–300
31.
WhiteWB. Defining the problem of treating the patient with hypertension and arthritis pain. Am J Med2009;122(5A):S3–9
32.
WalshJMMcDonaldKMShojaniaKG. Quality improvement strategies for hypertension management: a systematic review. Med Care2006;44(7):646–57
33.
ThompsonAECampbellNCCloutierL.,on behalf of the Canadian Hypertension Education Task Force. Tackling the burden of hypertension in Canada: encouraging collaborative care. Can Fam Phys2008;54:1659–62
